The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory.
In recent years muscarinic receptor agonists and cholinesterase inhibitors have been developed for the treatment of Alzheimer's disease. We have evaluated examples from both classes of compounds in rodent tests of reference and working memory, as well as tests that are sensitive to the side-eff...
Main Authors: | Dawson, G, Iversen, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1993
|
Similar Items
-
A comparison of the effects of the novel muscarinic receptor agonists L-689,660 and AF102B in tests of reference and working memory.
by: Dawson, G, et al.
Published: (1994) -
THE EFFECTS OF A CHOLINERGIC AGONIST AND CHOLINESTERASE-INHIBITORS IN A CONDITIONED SUPPRESSION OF DRINKING PARADIGM
by: Dawson, G, et al.
Published: (1990) -
Muscarinic Receptor Agonists and Antagonists
by: David R. Kelly, et al.
Published: (2001-02-01) -
The behavioral effects of heptyl physostigmine, a new cholinesterase inhibitor, in tests of long-term and working memory in rodents.
by: Dawson, G, et al.
Published: (1991) -
Comparison of the effects of selective and nonselective muscarinic agonists on cognition and thermoregulation in primates.
by: Rupniak, N, et al.
Published: (1992)